title: [Treatment of chronic hepatitis C].
authors.affiliation: Seksjon for leversykdommer Medisinsk klinikk Aker universitetssykehus 0514 Oslo. helge.bell@ioks.uio.no
authors.forename: Helge
authors.initials: H
authors.lastname: Bell
authors.forename: Olav
authors.initials: O
authors.lastname: Dalgard
authors.forename: Kristian
authors.initials: K
authors.lastname: Bjøro
authors.forename: Kjell Block
authors.initials: KB
authors.lastname: Hellum
authors.forename: Bjørn
authors.initials: B
authors.lastname: Myrvang
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000075202:Contraindications; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin